1. Home
  2. WLAC vs DERM Comparison

WLAC vs DERM Comparison

Compare WLAC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WLAC

Willow Lane Acquisition Corp. Class A Ordinary Shares

HOLD

Current Price

$10.99

Market Cap

219.1M

Sector

N/A

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$8.44

Market Cap

257.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLAC
DERM
Founded
2024
2014
Country
US
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.1M
257.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WLAC
DERM
Price
$10.99
$8.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.00
$12.67
AVG Volume (30 Days)
230.1K
103.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$56,134,000.00
Revenue This Year
N/A
$17.48
Revenue Next Year
N/A
$55.83
P/E Ratio
$784.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.96
$4.97
52 Week High
$15.19
$9.56

Technical Indicators

Market Signals
Indicator
WLAC
DERM
Relative Strength Index (RSI) 34.95 55.01
Support Level $10.87 $7.64
Resistance Level $11.32 $8.29
Average True Range (ATR) 0.37 0.45
MACD -0.03 -0.05
Stochastic Oscillator 13.06 69.62

Price Performance

Historical Comparison
WLAC
DERM

About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares

Willow Lane Acquisition Corp is a blank check company.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: